The Foundation for the Accreditation of Cellular Therapy (FACT) and the Joint Assurance Committee of ISCT and EBMT (JACIE) are pleased to announce that the Programa de Trasplante de Médula Ósea y Terapia Celular del Hospital Privado Universitario de Córdoba, in Córdoba, Argentina, has become the first program in Argentina and the second in Latin America to achieve accreditation through the FACT-JACIE International Accreditation Program.
This achievement marks an important milestone in advancing quality and safety in hematopoietic cell transplantation (HCT) and cellular therapy in Argentina and Latin America. It recognizes the program’s commitment to high standards of patient care, donor and recipient safety, and continuous quality improvement.
The FACT-JACIE Accreditation Program provides a collaborative pathway to accreditation through a joint evaluation process based on internationally recognized standards for clinical, collection, and processing activities. This accreditation reflects FACT and JACIE’s ongoing efforts to promote quality and expand access to accreditation throughout Latin America.
Ana Lisa Basquiera, MD, PhD, MSc, director of the Programa de Trasplante de Médula Ósea y Terapia Celular del Hospital Privado Universitario de Córdoba, commented:
“FACT-JACIE accreditation means much more than certification for our team. It recognises a culture built on quality, patient safety and continuous improvement, aligned with international standards of care. Becoming the first accredited centre in Argentina is a milestone for our institution and our country. We hope this achievement will help strengthen access, quality and safety in transplantation and cellular therapies, while paving the way for other programmes across the region.”
Charles Crawley, MD, FRCP, FRCPath, JACIE Working Party Chair, stated:
“We are delighted to see the FACT-JACIE framework supporting another centre in turning internationally recognised standards into everyday practice. This achievement demonstrates the important role of a shared quality framework in fostering consistency, continuous improvement, and high standards of care for patients and donors.”
Phyllis I. Warkentin, MD, FASTCT, FACT Chief Medical Officer, noted:
“Under the leadership of Program Director Ana Lisa Basquiera, MD, PhD, MSc, the Programa de Trasplante de Médula Ósea y Terapia Celular del Hospital Privado Universitario de Córdoba has achieved an important milestone in FACT-JACIE accreditation, signifying high quality in its patient care and laboratory services through the dedication of their entire team. FACT commends this program, its leadership and staff for their commitment to advancing quality and safety in hematopoietic cell transplantation and cellular therapy in Argentina.”
FACT and JACIE congratulate the Programa de Trasplante de Médula Ósea y Terapia Celular del Hospital Privado Universitario de Córdoba on this historic achievement and recognize the program's leadership and staff for their dedication to advancing quality cellular therapy practices.